Spirometric abnormalities following treatment for pulmonary tuberculosis in Ilorin, Nigeria

Niger Postgrad Med J. 2020 Jul-Sep;27(3):163-170. doi: 10.4103/npmj.npmj_18_20.

Abstract

Background: Pulmonary tuberculosis (PTB) contributes significantly to morbidity and mortality worldwide, and despite microbiological cure for the disease, many patients still demonstrate residual respiratory symptoms and spirometric abnormalities.

Aim and objectives: The study aimed at identifying the prevalence, pattern and factors associated with spirometric abnormalities in patients successfully treated for PTB in Ilorin, Nigeria.

Materials and methods: This was a hospital-based cross-sectional study at the pulmonary outpatient clinics of the University of Ilorin Teaching Hospital and Kwara State Specialist Hospital, Sobi, Ilorin. A total of 308 consenting patients who had been certified microbiologically cured for bacteriologically confirmed PTB in the preceding 3 years had assessment of residual pulmonary symptoms, spirometry and plain chest radiograph.

Results: The prevalence of abnormal spirometry following treatment for PTB was 72.1% (confidence interval: 0.6682-0.7695), with restrictive pattern being the predominant abnormality (42.2%). Over half of the patients (56.5%) had at least one residual respiratory symptom. The significant predictors of abnormal spirometry were PTB retreatment (adjusted odds ratio [aOR] = 6.918; P = 0.012), increasing modified Medical Research Council dyspnoea scores (aOR = 7.935; P = 0.008) and increasing radiologic scores (aOR = 4.679; P ≤ 0.001) after treatment.

Conclusion: There is significant residual lung function impairment in majority of the individuals successfully treated for PTB in Ilorin. This highlights the need for spirometric assessment and follow-up after treatment.

Keywords: Ilorin; post-tuberculosis; spirometry; treatment.

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Lung / microbiology
  • Lung / physiopathology*
  • Male
  • Nigeria / epidemiology
  • Prevalence
  • Respiratory Function Tests / methods
  • Spirometry / statistics & numerical data*
  • Tuberculosis, Pulmonary / complications*
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / epidemiology

Substances

  • Antitubercular Agents